2020年COVID-19导致世界卫生组织西太平洋区和非洲区乙肝病毒免疫覆盖率下降的影响
研究使用已发表的数学模型,估算2020年出生儿童在乙肝疫苗出生剂量或第三剂覆盖率较2019年大流行前水平下降10%和20%时,西太平洋区和非洲区预期及超额乙肝病毒感染与相关死亡数。结果显示两区均出现额外慢性乙肝感染和超额死亡,支持维持免疫服务、补种疫苗并减轻未来出生队列接种中断的紧迫性。
要点
- 2020年乙肝疫苗接种覆盖率下降10%和20%可导致西太平洋区额外慢性HBV感染36,342–395,594例。
- 非洲区额外慢性HBV感染为9,793–502,047例,超额HBV相关死亡为1,177–67,727例。
- 西太平洋区超额HBV相关死亡为7,150–80,302例。
核心结论
- 乙肝疫苗接种覆盖率下降导致西太平洋区和非洲区出现额外慢性HBV感染及超额HBV相关死亡,支持维持免疫服务、实施补种并减轻未来出生队列接种中断的紧迫性。
研究设计与样本
- 使用已发表的数学模型,估算2020年出生儿童在乙肝疫苗出生剂量或第三剂覆盖率较2019年大流行前水平下降10%和20%时的预期及超额HBV感染与相关死亡数。
主要发现
- 西太平洋区额外慢性HBV感染为36,342–395,594例,超额HBV相关死亡为7,150–80,302例。
- 非洲区额外慢性HBV感染为9,793–502,047例,超额HBV相关死亡为1,177–67,727例。
关键数值与推荐
- 乙肝疫苗出生剂量或第三剂覆盖率较2019年大流行前水平下降10%和20%为模型评估的两种情景。
临床怎么用
- 原文结论支持维持免疫服务、实施补种并减轻未来出生队列乙肝疫苗接种中断的紧迫性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The World Health Organization-designated Western Pacific Region (WPR) and African Region (AFR) have the highest number of chronic hepatitis B virus (HBV) infections worldwide. The COVID-19 pandemic has disrupted childhood immunization, threatening progress toward elimination of hepatitis B by 2030. We used a published mathematical model to estimate the number of expected and excess HBV infections and related deaths after 10% and 20% decreases in hepatitis B birth dose or third-dose hepatitis B vaccination coverage of children born in 2020 compared with prepandemic 2019 levels. Decreased vaccination coverage resulted in additional chronic HBV infections that were 36,342-395,594 in the WPR and 9,793-502,047 in the AFR; excess HBV-related deaths were 7,150-80,302 in the WPR and 1,177-67,727 in the AFR. These findings support the urgent need to sustain immunization services, implement catch-up vaccinations, and mitigate disruptions in hepatitis B vaccinations in future birth cohorts.
引用
- Kabore HJ, Li X, Allison RD, et al. Effects of Decreased Immunization Coverage for Hepatitis B Virus Caused by COVID-19 in World Health Organization Western Pacific and African Regions, 2020. Emerg Infect Dis. 2022. PMID: 36502399. doi:10.3201/eid2813.212300
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。